1885.30
-4.53%
Emkay
MHL’s Q2FY25 print was in line with our estimates, with revenues growing 13% YoY, driven by B2C revenues improving 21% YoY.
Emkay decreased Buy price target of Metropolis Healthcare Ltd. to 2050.0 on 02 Jul, 2025.
More from Metropolis Healthcare Ltd.
Recommended